Request Copyright Permission

What Are Meaningful Device Improvements for Patients, Providers and Payers?

Pritchard JN.

Respiratory Drug Delivery 2014. Volume 1, 2014: 217-228.

Abstract:

The market for inhaled therapies is about to become extremely crowded as similar products are launched. History suggests that companies will attempt to differentiate their products in terms of device characteristics. While such actions have improved our understanding of patient-device interactions, device claims were not widely recognized by payers, or universally accepted by prescribers. To secure market share, companies will need credible clinical and pharmacoeconomic data to support their products. With marginal differences in efficacy and usability, it may be difficult to differentiate products, with the result that there is a very real possibility of significant price erosion due to competition. Niche products designed specifically for the young or old may be able to command a price premium. However, most current inhaler designs meet the needs of the general population for usability, and by far the biggest opportunity may not be to address how patients use their device, but how often.